Christopher MacRi

Senior Director, Business Development Clinical Analytics + CRO Innovation Practice at Revvity Signals

Christopher Macri has a diverse work experience spanning over several companies and industries. Christopher currently holds the position of Senior Director of Business Development for the Clinical Analytics Practice in the US and EMEA regions at Revvity Signals. Previously, they worked at PerkinElmer Informatics as a Senior Director of Business Development, where they focused on clinical analytics practice and translational and clinical analytics. Prior to that, they served as a Global Key Account Manager at PerkinElmer, Inc. Christopher also held roles such as Major Account Manager at PerkinElmer Informatics, Director of Business Development at Entelos, and Senior Manager of NAFTA Business Operations at BASF. Christopher has also worked at companies like Ingenuity Systems, Metabolon, Accelrys, and Bio-Rad Laboratories, where they held various sales and business development positions. Christopher's expertise lies in driving business growth and developing strategic partnerships in the field of healthcare and life sciences.

Christopher Macri attended Horace Mann School from 1985 to 1989. Christopher then went on to study Biology at Washington University in St. Louis from 1989 to 1993, earning their BA degree.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Revvity Signals

1 followers

Revvity Signals Software, formerly PerkinElmer Informatics, has more than three decades providing unrivaled support for scientific workflows. Our powerful informatics solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. Now under our comprehensive Signals Research Suite, our end-to-end SaaS solution integrates workflows across biology, chemistry and materials new product development to accelerate scientific innovation, and help scientists help each other. In addition, our robust solution, powered by TIBCO® Spotfire®, can revolutionize the clinical trial process. From our internationally recognized flagship ChemDraw® and E-Notebook applications, to our Signals Research Suite (Signals Notebook, Signals VitroVivo and Signals Inventa) to our exclusive TIBCO® Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.